NCT07891897

Brief Summary

This study aims to evaluate the performance of an automated subjective refraction system that operates a digital phoropter. By comparing its results with those obtained through conventional subjective refraction performed by an optometrist, the study will assess the agreement in refractive prescriptions and examine examination efficiency, repeatability, and participant experience, thereby providing evidence for the further application of automated subjective refraction technology.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
508

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Nov 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 23, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

October 23, 2026

Status Verified

September 1, 2026

Enrollment Period

2 months

First QC Date

October 11, 2026

Last Update Submit

October 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement in refractive prescriptions between automated and optometrist-performed subjective refraction

    Agreement between automated subjective refraction and optometrist-performed subjective refraction will be evaluated using measurements from the right eye as the primary analysis eye. The paired differences in spherical power and cylindrical power, measured in diopters (D), and cylinder axis, measured in degrees, will be analyzed using Bland-Altman analysis to estimate the mean difference (bias) and 95% limits of agreement. Intraclass correlation coefficients (ICCs) will also be calculated. The prespecified clinically acceptable limits are ±0.25 D for spherical and cylindrical power and ±5 degrees for cylinder axis.

    Day 1, after completion of both subjective refraction examinations.

Secondary Outcomes (4)

  • Examination time for each subjective refraction method

    Day 1, during each subjective refraction examination.

  • Repeatability of the automated subjective refraction system

    Day 1, after completion of both automated subjective refraction measurements

  • Agreement between the two subjective refraction methods under cycloplegic and non-cycloplegic conditions

    Day 1, after completion of both subjective refraction examinations.

  • Participant acceptance, comfort, and satisfaction with the automated refraction procedure

    Day 1, immediately after completion of both subjective refraction examinations.

Study Arms (2)

Automated Refraction First

EXPERIMENTAL

Participants first undergo subjective refraction using the automated program-controlled refraction system, followed by a rest interval of at least 20 minutes and then subjective refraction performed by an optometrist. Pediatric participants undergo cycloplegia before both examinations. The first 50 adult participants undergo an additional automated refraction examination for repeatability assessment.

Diagnostic Test: Automated Program-Controlled Subjective RefractionDiagnostic Test: Optometrist-Performed Subjective Refraction

Optometrist Refraction First

EXPERIMENTAL

Participants first undergo subjective refraction performed by an optometrist, followed by a rest interval of at least 20 minutes and then subjective refraction using the automated program-controlled refraction system. Pediatric participants undergo cycloplegia before both examinations. The first 50 adult participants undergo an additional automated refraction examination for repeatability assessment.

Diagnostic Test: Automated Program-Controlled Subjective RefractionDiagnostic Test: Optometrist-Performed Subjective Refraction

Interventions

Subjective refraction is performed using an automated program operating a standard phoropter to determine sphere, cylinder, and axis. The system incorporates an in-house AI algorithm that has not been registered as a medical device. Its results are used for research purposes only and do not guide spectacle prescription or other clinical decisions. The first 50 adult participants undergo a second automated measurement for repeatability assessment.

Automated Refraction FirstOptometrist Refraction First

Subjective refraction is independently performed by a qualified optometrist according to a standardized operating procedure to determine sphere, cylinder, and axis. The optometrist is unaware of the results generated by the automated refraction system when performing the examination.

Automated Refraction FirstOptometrist Refraction First

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Children aged 7-16 years or adults aged 18 years or older, of either sex.
  • Astigmatism magnitude of 1.50 D or less. ③ Children must be able to undergo cycloplegia. ④ Voluntary participation in the study with written informed consent.

You may not qualify if:

  • Concomitant ocular diseases causing opacity of the ocular media, such as cataract, glaucoma, or fundus disease.
  • History of ocular trauma or intraocular surgery.
  • Manifest strabismus or significant binocular vision dysfunction.
  • Inability to follow and respond to system instructions. ⑤ Only one eye meeting the eligibility criteria.
  • Considered unsuitable for participation by the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2026

First Posted

October 23, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 28, 2027

Last Updated

October 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

No external sharing of individual participant data is currently planned.